| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) | Autophagy | 2021 | 440 |
| Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study | Journal of Hepatology | 2021 | 151 |
| Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0 | Neurogastroenterology and Motility | 2021 | 146 |
| Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU | Journal of Crohn's and Colitis | 2021 | 78 |
| P641 Impact of lockdown period due to COVID-19 pandemic in patients with Inflammatory Bowel Disease | Journal of Crohn's and Colitis | 2021 | 78 |
| P531 SARS-CoV-2 infection in Elderly patients with Inflammatory Bowel Disease with or without immunosuppressants during the first year of the pandemic. An observational, descriptive, cohort study | Journal of Crohn's and Colitis | 2021 | 78 |
| P626 SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease | Journal of Crohn's and Colitis | 2021 | 78 |
| DOP40 Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study | Journal of Crohn's and Colitis | 2021 | 78 |
| COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? | Journal of Internal Medicine | 2021 | 75 |
| Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study | Gastroenterology | 2021 | 64 |
| Systemic treatment of hepatocellular carcinoma: An EASL position paper | Journal of Hepatology | 2021 | 49 |
| PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis | Journal of Hepatology | 2021 | 41 |
| European Registry on management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients | Gut | 2021 | 41 |
| Role of liver sinusoidal endothelial cells in liver diseases | Nature Reviews Gastroenterology and Hepatology | 2021 | 36 |
| Endoscopic Ultrasound-guided Fine-needle Biopsy With or Without Rapid On-site Evaluation for Diagnosis of Solid Pancreatic Lesions: A Randomized Controlled Non-Inferiority Trial | Gastroenterology | 2021 | 36 |
| Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy | Journal of Viral Hepatitis | 2021 | 32 |
| Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment | ELife | 2021 | 31 |
| Expanding controlled donation after the circulatory determination of death: statement from an international collaborative | Intensive Care Medicine | 2021 | 29 |
| Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease | Journal of Hepatology | 2021 | 28 |
| Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests | Nature Reviews Gastroenterology and Hepatology | 2021 | 27 |
| Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS) | Journal of Hepatology | 2021 | 25 |
| CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis | Journal of Hepatology | 2021 | 25 |
| rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis | Journal of Hepatology | 2021 | 24 |
| Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty? | Journal of Hepatology | 2021 | 22 |
| Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients | American Journal of Transplantation | 2021 | 22 |
